Evidence map›Paper›PMID 41857550›Full record

ArticleBMC medical research methodology2026

How reliable are ROC cut-offs? Evidence from simulation and empirical analysis.

Yashaswini K, Priyanka K

Abstract read
In one paragraph

Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yashaswini KDepartment of Biostatistics, Nitte Institute of Allied Health Sciences, K.S. Hegde Medical Academy, Nitte (Deemed to be University), Mangalore, Karnataka, India. yashaswinik33@gmail.com.ORCID http://orcid.org/0009-0001-0193-1259
Priyanka KAJ Hospital and Research Centre, Mangalore, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReceiver Operating Characteristic (ROC) analysis is commonly used to evaluate how well biomarkers distinguish between diseased and non-diseased individuals. A very important step in this process is choosing an appropriate cut-off value. Although many ROC-based cut-off methods exist, they often lead to different decisions, and guidance on which methods work reliably in practice is limited.

objectiveTo compare commonly used ROC-based cut-off selection methods and identify those that provide stable and balanced diagnostic performance under realistic data conditions.

methodsWe conducted extensive simulation studies using symmetric, skewed, and mixed continuous predictors, varying effect size, variance, and sample size. Multiple ROC-based cut-off methods were evaluated using sensitivity and specificity as the primary performance measures. Findings were further validated using real-world datasets involving blood-based biomarkers.

resultsThe sensitivity and specificity curves showed that across all simulations and real-world datasets, Youden’s index, accuracy-based methods, Cohen’s kappa, and the product of sensitivity and specificity consistently produced stable and well-balanced sensitivity and specificity. In contrast, methods such as the F1 score, ROC01, odds ratio, and risk ratio often produced highly variable results, favouring one diagnostic measure at the expense of the other.

conclusionYouden’s index and the product of sensitivity and specificity offer the most reliable and practical choices for cut-off selection across a wide range of conditions. While other methods may be useful for specific goals, they should be applied with caution in routine diagnostic and prognostic settings.

Indexed as

BiomarkersROC CurveAlgorithmsComputer SimulationHumansReproducibility of ResultsSensitivity and SpecificityBiomarkersDiagnostic cut-offROC analysisSensitivitySpecificityYouden’s index

Identifiers

PMID41857550
PMCPMC13123023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.